SCHEMBL4144034

SCHEMBL4144034

CC1CNCCN1c1cccc2cccnc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 4/20 0.59
HTR2A P28223 3/20 0.59
SLC6A4 P31645 1/20 0.59
HTR2B P41595 3/20 0.45
LATS1 O95835 1/20 0.44
PRKD3 O94806 2/20 0.42
PRKCG P05129 2/20 0.42
PRKCB P05771 2/20 0.42
PRKCA P17252 2/20 0.42
PRKACA P17612 2/20 0.42
PRKACG P22612 2/20 0.42
PRKACB P22694 2/20 0.42
PRKCH P24723 2/20 0.42
PRKCI P41743 2/20 0.42
PRKCE Q02156 2/20 0.42
PRKCQ Q04759 2/20 0.42
PRKCZ Q05513 2/20 0.42
PRKCD Q05655 2/20 0.42
PRKD1 Q15139 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4134028 0.84 HTR2C (0.57) HTR2CHTR2ASLC6A4HTR2BTSHR
SCHEMBL4135513 0.84 HTR2C (0.59) HTR2CHTR2ASLC6A4HTR2BSMN1; SMN2
SCHEMBL4146589 0.84 HTR2C (0.59) HTR2CHTR2ASLC6A4HTR2BSMN1; SMN2
SCHEMBL4140106 0.83 HTR2C (0.56) HTR2CHTR2ASLC6A4HTR2BTSHR
SCHEMBL1851412 0.82 HTR2C (0.48) HTR2CHTR2ASLC6A4HTR2BLATS1
SCHEMBL23578715 0.78 HTR2A (0.46) HTR2CHTR2ASLC6A4TSHRALOX15
SCHEMBL17889486 0.76 HTR6 (0.42) HTR2CHTR2AHTR2BLATS1GSK3B
SCHEMBL30575863 0.75 SPAST (0.43) HTR2CHTR2ASLC6A4HTR2BLATS1
SCHEMBL3566560 0.75 HTR6 (0.69) HTR2CHTR2AHTR2BLATS1PRKD3
SCHEMBL3563118 0.75 HTR6 (0.69) HTR2CHTR2AHTR2BLATS1PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054454-A1 BENZOFURANYL- AND BENZOTHIENYL- PIPERAZINYL QUINOLINES AND METHODS OF THEIR USE VENKATESAN ARANAPAKAM MUDUMBAI 2009-02-26 US disclosed
US-7276603-B2 serotonin receptor antagonists such as 8-{4-[2-(1-benzofuran-3-yl)ethyl]-1-piperazinyl}-6-fluoroquinoline, used for treatment and/or prevention of depression, anxiety and cognitive deficits arising from Alzheimer's disease, neurodegenerative disorders, schizophrenia and prostate cancer WYETH (US) 2007-10-02 US disclosed
CN-1812984-A Benzofuranyl-piperazinyl and benzothienyl-piperazinyl quinolines as 5-hydroxytryptamine reuptake inhibitors WHETH CORP (US) 2006-08-02 CN disclosed
EP-1641785-A2 BENZOFURANYL-AND BENZOTHIENYL-PIPERAZINYL QUINOLINES AS SEROTONIN REUPTAKE INHIBITORS Wyeth (US) 2006-04-05 EP disclosed
US-20050059673-A1 Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use WYETH 2005-03-17 US disclosed
WO-2004099191-A2 BENZOFURANYL-AND BENZOTHIENYL-PIPERAZINYL QUINOLINES AS SEROTONIN REUPTAKE INHIB ITORS WYETH (US) 2004-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054454-A1 BENZOFURANYL- AND BENZOTHIENYL- PIPERAZINYL QUINOLINES AND METHODS OF THEIR USE TPH1, TPH2, HTR2C HTR2C 3/4885HTR2A 7/4885SLC6A4 14/4885
US-20050059673-A1 Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use TPH1, TPH2, HTR2C HTR2C 3/4885HTR2A 7/4885SLC6A4 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.